Two novel type 2 diabetes loci revealed through integration of TCF7L2 DNA occupancy and SNP association data
Matthew E. Johnson(Children's Hospital of Philadelphia), Struan F.A. Grant(Children's Hospital of Philadelphia), Klaus H. Kaestner(Children's Hospital of Philadelphia), Qianghua Xia(Tianjin Medical University), Jonathan Schug(Institut thématique Génétique, génomique et bioinformatique), Jesús Sainz(deCODE Genetics (Iceland)), Sandra Deliard(Children's Hospital of Philadelphia), Vanessa C. Guy(Children's Hospital of Philadelphia), Andrew D. Wells(Children's Hospital of Philadelphia), Jianhua Zhao(Southwest Petroleum University)
Cited by 19
Related Papers
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis
|Nature Genetics|2020|815
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
|Nature Genetics|2007|528
Common variants at five new loci associated with early-onset inflammatory bowel disease
|Nature Genetics|2009|483